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SHORT COMMUNICATION
Trends in eye cancer mortality among adults in the USA and England and
Wales
AJE Foss' and PJ Dolin2
Departments of'Clinical Science and 2Preventive Ophthalmology, Institute of Ophthalmology, Bath Street, London, UK.
Summary Trends in eye cancer mortality are presented for the USA and England and Wales during the
period 1955-89. Mortality rates have fallen by 58% in the USA during this period. The fall in mortality is
paralleled by an equal fall in incidence rates in the USA. In England and Wales, mortality rates and incidence
rates have remained relatively constant during the last three decades. The explanation for these differences
between the USA and England and Wales is unknown.
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Eye cancers are rare tumours, accounting for less than 0.1%
of all cancer deaths in the USA and England and Wales. In
childhood, most eye cancers are retinoblastomas and
rhabdomyosarcomas, whereas in adults about 90% of eye
cancers are melanomas (Hakulinen et al., 1978), mainly ofthe
uveal tract (Scotto et al., 1976).
Little is known about the epidemiology of adult cancers or
ocular melanomas. Several epidemiological studies have
studied the role of solar ultraviolet radiation and have
provided only limited support for it being an aetiological
factor for ocular melanoma (Tucker et al., 1985; Seddon et
al., 1990a; Holly et al., 1990; Gallagher et al., 1985).
Occupational hazards associated with ocular melanoma
include welding exposure, asbestos exposure and working as
a chemist or chemical technician (Tucker et al., 1985; Holly et
al., 1996). There has been one report of a small cluster of
cases seen at one chemical works, but no causative agent was
identified (Albert et al., 1980). Polychlorinated biphenyls have
been suggested as a risk factor for cutaneous melanoma but
not for uveal melanoma (Davidorf and Knupp, 1979).
This study examines eye cancer incidence and mortality
among adults in the USA and England and Wales.
Materials and methods
Eye cancers are coded under the ICD system ICD-6:192,
ICD-7:192 (World Health Organization, 1957), ICD-8:190
(World Health Organization, 1967) and ICD-9:190 (World
Health Organization, 1978) and include cancers of the
eyeball, orbit, lachrymal gland, conjunctiva, cornea, retina
and lachrymal sac but excludes cancers of the eyelid and
orbital bone, and all cancers in which the eye is a secondary
site.
This analysis concentrates on eye cancers in persons aged
40 or older. Ninety per cent of cases of cancer of the eye in
adults are ocular melanomas; the large majority of these are
of the uveal tract, and it has become standard practice to
take eye cancers in adults as a surrogate measure for uveal
melanoma (Hakulinen et al., 1978; Strickland and Lee, 1981;
Swerdlow, 1983). There are few deaths from cancer of the eye
in either the USA or England and Wales in people under the
age of 40 years, and mortality rates in this age group are thus
negligible and have been excluded from this report.
Data on the number of eye cancer deaths and population
estimates during the period 1955-89, in 5 year age groups
and 5 year calendar periods, were provided by the
International Agency for Research on Cancer. Data on the
incidence of cancer of the eye during 1973-89 were provided
for the USA by the SEER Program of the National Cancer
Institute and for England and Wales by the Office of
Population Censuses and Surveys (OPCS).
To facilitate the comparison of rates between countries and
across time, rates were directly age standardised to the world
population (International Union against, Cancer, 1970).
Results
Mortality rates
Age-standardised mortality rates for men and women aged 40
and older by 5 year calendar periods during 1955-89 for the
USA and England and Wales are shown in Figure 1. The
USA mortality rate has dramatically fallen over the 35 year
period. The male rate has fallen from 0.49 deaths per 100 000
men in 1955-59 to 0.22 in 1985-89, a 55% reduction.
Similarly, the USA female rate has fallen from 0.41 per
100 000 women in 1955-59 to 0.17 in 1985-89, a reduction
of 59%.
In England and Wales, there is little indication that either
the male or female mortality rate had fallen during the last
three decades. The 1985-89 rates are virtually identical to
the 1955-59 rates. There is, however, an indication that
mortality rates among women may have started to fall in
recent years. From a peak of 0.58 deaths per 100 000 women
in 1970-74, the female rate has fallen slightly during the
three subsequent 5 year periods. More recent data from
England and Wales (not shown) indicate the female rate is
continuing to fall. For the 3 year period 1990-92, the rate
was 0.43 deaths per 100 000 women.
An important feature of Figure 1 is that the USA rates
were similar to the England and Wales rates in 1955-59. In
1985-89 the male mortality rate for England and Wales was
0.59 deaths per 100 000 population, whereas the USA rate
was 0.22 deaths, a 2.7-fold difference. A similar difference is
found in female rates.
Examination of age-specific rates has shown that the
dramatic fall in mortality rates in the USA occurred across
all age groups examined for both men and women. For
England and Wales, there is little evidence that age-specific
rates among men have fallen in any age group. Among
women, there has been an apparent reduction in female
mortality rates since 1970-74 among the oldest age groups
only.
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Figure 1 Age-standardised mortality rates, per 100000, from eye
cancer for men and women over the age of 40 years from 1955-
89. (a) USA and (b) England and Wales. _, Men; - --, women.
Incidence rates
Figure 2 shows the age-standardised incidence rates in the
USA for 1973-89 and in England and Wales for 1971-88.
In the USA, the male age-standardised incidence rate has
fallen from 1.98 cases per 100 000 men during 1973-74 to
1.49 cases in 1985-89, which is a reduction of 25%. The
USA female incidence rate also shows a downward trend,
falling from 1.33 in 1973-74 to 0.98 in 1985-89, which is a
28% reduction. In England and Wales, incidence rates have
fluctuated, with little evidence of a downward trend in either
age-standardised rates or age-specific rates for either men or
women.
Discussion
The main finding from this study is that the mortality rates
for cancer of the eye have fallen by over 50% in the USA
since 1955, but no such fall has occurred in England and
Wales. The striking difference in mortality patterns between
the two countries may indicate real differences or may simply
reflect an artefact in the data.
Changes in coding practices
There has been one change in the coding of eye cancers
during the study period. Tumours of the optic nerve are
Figure 2 Age-standardised incidence rates, per 100000, of eye
cancer for men and women over the age of 40. (a) USA 1973 -89)
and (b) England and Wales (1971-88). , Men; ---, women.
included in ICD-6:192 and ICD-7:192 but are excluded from
ICD-8:190 and ICD-9:190. This change in coding practice
applies equally to England and Wales and the USA. Also,
optic nerve tumours are extremely rare and would be
expected to have little impact on eye cancer rates.
Changes in diagnostic criteria
In contrast to many tumours, the diagnosis of uveal
melanoma is made on clinical examination as biopsies of
intraocular masses are not without risk and many uveal
melanomas are treated by radiotherapy. Therefore, patholo-
gical confirmation of the diagnosis is not available for the
majority of cases. Despite this, there has been little change in
diagnostic criteria with time and no differences in criteria
have been reported between the USA and England and
Wales. For those cases coming to pathological examination,
the diagnostic criteria have remained remarkably constant,
and they are still classified according to the Callender
classification described in 1931 (Callendar, 1931; Wilder and
Callendar, 1939).
Changes in survival
During the study period a number of new techniques were
introduced in both countries that allowed sharing of the
ocular globe, such as brachytherapy, proton beam radio-
therapy and trans-scleral local resection. However, these new
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techniques have not improved survival (Augsburger 1990;
Seddon et al., 1990b; Foulds et al., 1987, 1991). In addition,
no satisfactory treatment for metastatic uveal melanoma
existed during the study period (Albert et al., 1992).
In England and Wales, survival for adult eye cancers has
remained steady over the last two decades. During 1971-74,
5 year survival was 59%, and in 1980-84 the 5 year survival
was 61% (unpublished OPCS data). However, there have
been reports from Denmark and Sweden of slight improve-
ments in survival, but it is extremely unlikely that this would
be of sufficient magnitude to result in a 50% fall in mortality.
Discussion with ophthalmic oncologists in the USA does not
suggest any dramatic move towards earlier detection or a
more informed public in the USA compared with England
and Wales.
Changes in incidence
The alternative explanation is that mortality rates in the USA
have fallen because the underlying incidence rates have also
fallen, whereas in England and Wales underyling incidence
rates have remained relatively constant. Figure 2a shows the
age-standardise incidence rates in the USA for 1973- 1989 and
Figure 2b those for England and Wales for 1971-1988.
In the USA, the male age-standardised incidence rates fell
by 25% over an 18 year period from 1973 to 1989 (an annual
average fall of 1.4%), which parallels the observed 55% fall
in male mortality rates over 35 years (an annual average fall
of 1.6%). The USA female incidence rate also shows a
downward trend, falling by 28% over the same period. In
England and Wales, incidence rates have fluctuated with little
evidence of a downward trend in either age-standardised rates
or age-specific rates for either men or women. Although there
has been an apparent reduction in female mortality rates
since 1970-74 in England and Wales there has been no
corresponding fall in female incidence rates.
This observed fall in mortality and incidence rates in the
USA invites hypotheses about possible changes in exposure
risk factors. Unfortunately, at this time, little is known about
the aetiology of eye cancer in adults.
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